Dyne Therapeutics, Inc. (DYN) Insider Trading -- Recent Executive & Director Transactions

8 insiders reported 147 Form 4 transactions for Dyne Therapeutics, Inc. (DYN) over the past 18 months (most recent 2026-09-08). Recent activity: Kerr Douglas (Chief Medical Officer) Sell 3,745 shares, Cox John (CEO & President) Sell 5,658 shares, Friedl-Naderer Johanna (Chief Commercial Officer) Sell 900 shares, Kerr Douglas (Chief Medical Officer) Sell 1,290 shares, Friedl-Naderer Johanna (Chief Commercial Officer) Sell 185 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-09-08Kerr DouglasChief Medical OfficerSell3,745$91,191
2026-09-08Cox JohnCEO & PresidentSell5,658$106,823
2026-09-08Friedl-Naderer JohannaChief Commercial OfficerSell900$21,915
2026-09-08Kerr DouglasChief Medical OfficerSell1,290$24,355
2026-09-08Friedl-Naderer JohannaChief Commercial OfficerSell185$3,493
2026-08-17Rhodes Jason PDirectorSell1.4M$34.0M
2026-08-17Rhodes Jason PDirectorSell268,354$7.0M
2026-08-17Lucera ErickChief Financial OfficerSell1,797$47,225
2026-08-17Kerr DouglasChief Medical OfficerSell1,556$40,892
2026-08-17Friedl-Naderer JohannaChief Commercial OfficerSell226$5,939
2026-08-17Rhodes Jason PDirectorSell94,415$2.5M
2026-08-17Rhodes Jason PDirectorSell63,643$1.7M
2026-08-17Cox JohnCEO & PresidentSell4,986$131,032
2026-08-17Rhodes Jason PDirectorSell322,465$8.1M
2026-08-17Rhodes Jason PDirectorSell478,377$12.0M
2026-07-29Kersten DirkDirectorSell256,072$6.5M
2026-07-29Kersten DirkDirectorSell5,388$140,319
2026-07-08Rhodes Jason PDirectorSell49,193$1.1M
2026-07-08Rhodes Jason PDirectorSell253,039$5.8M
2026-07-08Rhodes Jason PDirectorSell127,182$2.9M
2026-07-08Rhodes Jason PDirectorSell100,019$2.3M
2026-07-08Rhodes Jason PDirectorSell124,379$2.9M
2026-07-08Rhodes Jason PDirectorSell29,587$698,845
2026-07-08Rhodes Jason PDirectorSell62,543$1.4M
2026-07-08Rhodes Jason PDirectorSell14,844$350,615

Source: SEC Form 4 filings · as of 2026-09-08